Question 1
How long has Dr. Harrington been the medical director for a Class 4 therapeutic laser company?
Question 2
What is a common conclusion among studies regarding photobiomodulation (PBM) for cancer patients?
Question 3
How does local immune response factor into tumor control according to the study on mice?
Question 4
Which email can be used to contact Dr. Phil Harrington?
Question 5
What is one of the main concerns when making treatment decisions from a Medical Legal standpoint?
Question 6
What did the study on cost effectiveness of laser therapy in head and neck cancer patients conclude?
Question 7
What does Dr. Harrington illustrate with the example of not punching someone in the face?
Question 8
What are the two categories of decision-making discussed by Dr. Phil Harrington regarding the use of lasers on cancer patients?
Question 9
What is Dr. Harrington's personal stance on using lasers over tumor sites for himself or family?
Question 10
What specific condition related to cancer patients does photobiomodulation help prevent?
Question 11
Which 2015 study suggests low power laser irradiation might treat which type of cancer?
Question 12
What main factor differentiates the physiological perspective from the medical legal perspective according to Dr. Harrington?
Question 13
What was the conclusion of the study on laser therapy's impact on tumor growth in mice?
Question 14
Why does Dr. Harrington recommend against using lasers on cancer patients from a medical-legal perspective?
Question 15
In Dr. Harrington's discussion, what scientific evidence supports the safety of PBM in treating cancer patients?